The White Paper examines competitive issues involving healthcare intermediaries. The analysis highlights growing concerns over potentially anticompetitive practices by intermediaries and their impact not only on traditional competition metrics but also on important healthcare policy objectives. Three case studies provide timely and relevant examples, including: pediatric vaccines and Physician Buying Groups, recent drug shortages and Group Purchasing Organizations, and consumer choice involving pharmacies and Pharmacy Benefit Managers.
The Healthcare Supply Chain Association (HSCA) offers a response to the AAI white paper in a recent letter.
